BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36190291)

  • 1. A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications.
    Earl J; Calabuig-Fariñas S; Sarasquete ME; Muinelo Romay L; Lopez-Tarruella S; Bellosillo Paricio B; Rodríguez M; Valencia Leoz K; Dueñas Porto M; Tarazona N; Hernandez Losa J; Toledo RA
    J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy, a paradigm shift in oncology: what interventional radiologists should know.
    Calandri M; Siravegna G; Yevich SM; Stranieri G; Gazzera C; Kopetz S; Fonio P; Gupta S; Bardelli A; Veltri A; Odisio BC
    Eur Radiol; 2020 Aug; 30(8):4496-4503. PubMed ID: 32193642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
    Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
    Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies.
    Zavridou M; Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Lianidou E
    Clin Chem; 2018 Oct; 64(10):1522-1533. PubMed ID: 30018056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles.
    Corvigno S; Johnson AM; Wong KK; Cho MS; Afshar-Kharghan V; Menter DG; Sood AK
    Mol Cancer Ther; 2022 Jul; 21(7):1067-1075. PubMed ID: 35545008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Liquid Biopsy - A new diagnostic concept in oncology].
    Heidrich I; Roeper CMT; Rautmann C; Pantel K; Smit DJ
    Dtsch Med Wochenschr; 2023 May; 148(10):597-604. PubMed ID: 37105187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
    Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
    Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liquid Biopsy - A new diagnostic concept in oncology].
    Heidrich I; Roeper CMT; Rautmann C; Pantel K; Smit DJ
    Laryngorhinootologie; 2024 Jan; 103(1):40-46. PubMed ID: 37748502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
    Fici P
    Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Molecular Markers in Glioblastoma-Benefits of Liquid Biopsy.
    Birkó Z; Nagy B; Klekner Á; Virga J
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053907
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
    Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
    Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging on-chip electrokinetic based technologies for purification of circulating cancer biomarkers towards liquid biopsy: A review.
    Shi L; Esfandiari L
    Electrophoresis; 2022 Jan; 43(1-2):288-308. PubMed ID: 34791687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid Biopsy beyond Circulating Tumor Cells and Cell-Free DNA.
    Junqueira-Neto S; Batista IA; Costa JL; Melo SA
    Acta Cytol; 2019; 63(6):479-488. PubMed ID: 30783027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
    Russano M; Napolitano A; Ribelli G; Iuliani M; Simonetti S; Citarella F; Pantano F; Dell'Aquila E; Anesi C; Silvestris N; Argentiero A; Solimando AG; Vincenzi B; Tonini G; Santini D
    J Exp Clin Cancer Res; 2020 May; 39(1):95. PubMed ID: 32460897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy in lung cancer.
    Li L; Jiang H; Zeng B; Wang X; Bao Y; Chen C; Ma L; Yuan J
    Clin Chim Acta; 2024 Feb; 554():117757. PubMed ID: 38184141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy: From Basic Research to Clinical Practice.
    Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
    Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.